Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117332) titled 'Cinobufacin Combined with PD-1 inhibitor for hepatocellular carcinoma' on Jan. 22.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
Hepatocellular carcinoma
Intervention:
PD-1 inhibitor group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-31
Target Sample Size: PD-1 inhibitor group:250;Cinobufacini combined with PD-1 inhibitor group:250;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307037
Disclaimer: Curated by H...